Clinical Trial: NRG HN016

NRG HN016

Status: New, Open

Radiotherapy with Concurrent Cetuximab vs. Carboplatin and Paclitaxel in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin: A Pragmatic Phase III Randomized Trial (CONCISE)

Eligible for screening study DCP 001